This information was published on 2026-07-04T00:08:51 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2632733 (IR 1905098) |
| (220) |
03 Feb 2026
|
| (511) (510) |
Class 44
Medical screening; medical testing services for diagnostic or treatment purposes; DNA screening for medical purposes. |
| (540) | CANCERNEXT |
| (550) | Word |
| (730) |
AMBRY GENETICS CORPORATION
|
Find out more about publications on the About page.